References
- ShweikiDItinASofferDKeshetEVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature199235963988438551279431
- DvorakHFBrownLFDetmarMDvorakAMVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisAm J Pathol19951465102910397538264
- AdamisAPMillerJWBernalMTIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol199411844454507943121
- HeraRKeramidasMPeoc’hMMouillonMRomanetJPFeigeJJExpression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degenerationAm J Ophthalmol2005139458959615808152
- Pe’erJFolbergRItinAGnessinHHemoIKeshetEVascular endothelial growth factor upregulation in human central retinal vein occlusionOphthalmology199810534124169499769
- FunkMKriechbaumKPragerFIntraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumabInvest Ophthalmol Vis Sci20095031025103219060280
- FunatsuHYamashitaHNomaHAqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patientsGraefes Arch Clin Exp Ophthalmol200524313815258777
- RohMIKimHSSongJHLimJBKohHJKwonOWConcentration of cytokines in the aqueous humor of patients with naïve, recurrent and regressed CNV associated with AMD after bevacizumab treatmentRetina200929452352919262441
- RohMILimSJAhnJMLimJBKwonOWConcentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injectionGraefes Arch Clin Exp Ophthalmol2010248563564019997926
- LaiTYLiuDTChanKPLukFOPangCPLamDSVisual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trialRetina20092991218122619934816
- ElshalMFMcCoyJPMultiplex bead array assays: performance evaluation and comparison of sensitivity to ELISAMethods200638431732316481199
- YoungSHAntoniniJMRobertsJRErdelyADZeidler-ErdelyPCPerformance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent modelsJ Immunol Methods20083311–2596818089291
- ChalamKVBalaiyaSMurthyRKAccurate estimation of vascular endothelial growth factor levels in microsamples with a low-cost bead-based assayRetina201030581581920084052
- FlowerLAhujaRHHumphriesSEMohamed-AliVEffects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptinCytokine200012111712171611052823
- FriebeAVolkHDStability of tumor necrosis factor alpha, interleukin 6, and interleukin 8 in blood samples of patients with systemic immune activationArch Pathol Lab Med2008132111802180618976019
- CampochiaroPAChoyDFDoDVMonitoring ocular drug therapy by analysis of aqueous samplesOphthalmology2009116112158216419700195
- AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med199433122148014877526212
- WellsJAMurthyRChibberRLevels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisationBr J Ophthalmol19968043633668703891
- RosenlingTSlimCLChristinCThe effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF)J Proteome Res20098125511552219845411
- AzizNNishanianPMitsuyasuRDetelsRFaheyJLVariables that affect assays for plasma cytokines and soluble activation markersClin Diagn Lab Immunol19996189959874670
- FiedlerGMBaumannSLeichtleAStandardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometryClin Chem200753342142817272489
- RichardsonMRPriceMOPriceFWProteomic analysis of human aqueous humor using multidimensional protein identification technologyMol Vis2009152740275020019884